title: The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
abstract: The formation of ligand-protein complexes requires simultaneous adaptation of the binding partners. In structure based virtual screening, high throughput docking approaches typically consider the ligand flexibility, but the conformational freedom of the protein is usually taken into account in a limited way. The goal of this study is to elaborate a methodology for incorporating protein flexibility to improve the virtual screening enrichments on GPCRs. Explicit-solvated molecular dynamics simulations (MD) were carried out in lipid bilayers to generate an ensemble of protein conformations for the X-ray structures and homology models of both aminergic and peptidergic GPCRs including the chemokine CXCR4, dopamine D3, histamine H4, and serotonin 5HT6 holo receptor complexes. The quality of the receptor models was assessed by enrichment studies to compare X-ray structures, homology models, and snapshots from the MD trajectory. According to our results, selected frames from the MD trajectory can outperform X-ray structures and homology models in terms of enrichment factor and AUC values. Significant changes were observed considering EF1% values: comparing the original CXCR4, D3, and H4 targets and the additional 5HT6 initial models to that of the best MD frame resulted in 0 to 6.7, 0.32 to 3.5 (10×), 13.3 to 26.7 (2×), and 0 to 14.1 improvements, respectively. It is worth noting that rank-average based ensemble evaluation calculated for different ensemble sizes could not improve the results further. We propose here that MD simulation can capture protein conformations representing the key interacting points of the receptor but less biased toward one specific chemotype. These conformations are useful for the identification of a "consensus" binding site with improved performance in virtual screening.
authors.affiliation: Discovery Chemistry, Gedeon Richter plc. , 19-21 Gyömrői út, H-1103 Budapest, Hungary.
authors.forename: Akos
authors.initials: A
authors.lastname: Tarcsay
authors.forename: Gábor
authors.initials: G
authors.lastname: Paragi
authors.forename: Márton
authors.initials: M
authors.lastname: Vass
authors.forename: Balázs
authors.initials: B
authors.lastname: Jójárt
authors.forename: Ferenc
authors.initials: F
authors.lastname: Bogár
authors.forename: György M
authors.initials: GM
authors.lastname: Keserű
mesh_terms: D019540:Area Under Curve; D001665:Binding Sites; D018360:Crystallography, X-Ray; D057166:High-Throughput Screening Assays; D006801:Humans; D008024:Ligands; D008051:Lipid Bilayers / Q000737:chemistry; D062105:Molecular Docking Simulation; D056004:Molecular Dynamics Simulation; D011485:Protein Binding; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D019718:Receptors, CXCR4 / Q000737:chemistry*; D050637:Receptors, Dopamine D3 / Q000737:chemistry*; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry*; D011968:Receptors, Histamine / Q000737:chemistry*; D000074040:Receptors, Histamine H4; D011985:Receptors, Serotonin / Q000737:chemistry*; D040681:Structural Homology, Protein; D013816:Thermodynamics; D014584:User-Computer Interface
chemical_list: C527276:CXCR4 protein, human; C418607:HRH4 protein, human; D008024:Ligands; D008051:Lipid Bilayers; D019718:Receptors, CXCR4; D050637:Receptors, Dopamine D3; D043562:Receptors, G-Protein-Coupled; D011968:Receptors, Histamine; D000074040:Receptors, Histamine H4; D011985:Receptors, Serotonin; C097216:serotonin 6 receptor